首页> 外文期刊>BMC Medical Genetics >Case reports of juvenile GM1 gangliosidosisis type II caused by mutation in GLB1 gene
【24h】

Case reports of juvenile GM1 gangliosidosisis type II caused by mutation in GLB1 gene

机译:GLB1基因突变引起II型少年GM1神经节病的病例报告

获取原文
           

摘要

Background Type II or juvenile GM1-gangliosidosis is an autosomal recessive lysosomal storage disorder, which is clinically distinct from infantile form of the disease by the lack of characteristic cherry-red spot and hepatosplenomegaly. The disease is characterized by slowly progressive neurodegeneration and mild skeletal changes. Due to the later age of onset and uncharacteristic presentation, diagnosis is frequently puzzled with other ataxic and purely neurological disorders. Up to now, 3–4 types of GM1-gangliosidosis have been reported and among them type I is the most common phenotype with the age of onset around 6?months. Various forms of GM1-gangliosidosis are caused by GLB1 gene mutations but severity of the disease and age of onset are directly related to the position and the nature of deleterious mutations. However, due to its unique genetic cause and overlapping clinical features, some researchers believe that GM1 gangliosidosis represents an overlapped disease spectrum instead of four distinct types. Case presentation Here, we report a less frequent type of autosomal recessive GM1 gangliosidosis with perplexing clinical presentation in three families in the southwest part of Iran, who are unrelated but all from “Lurs” ethnic background. To identify disease-causing mutations, Whole Exome Sequencing (WES) utilizing next generation sequencing was performed. Four patients from three families were investigated with the age of onset around 3?years old. Clinical presentations were ataxia, gate disturbances and dystonia leading to wheelchair-dependent disability, regression of intellectual abilities, and general developmental regression. They all were born in consanguineous families with no previous documented similar disease in their parents. A homozygote missense mutation in GLB1 gene (c. 601?G?>?A, p.R201C) was found in all patients. Using Sanger sequencing this identified mutation was confirmed in the proband, their parents, grandparents, and extended family members, confirming its autosomal recessive pattern of inheritance. Conclusions Our study identified a rare pathogenic missense mutation in GLB1 gene in patients with complex neurodevelopmental findings, which can extend the list of differential diagnoses for childhood ataxia in Iranian patients.
机译:背景II型或少年GM1神经节病是一种常染色体隐性遗传的溶酶体贮积病,由于缺乏特征性的樱桃红色斑点和肝脾肿大,因此在临床上与该疾病的婴儿形式不同。该疾病的特征是缓慢进行性神经变性和轻度骨骼变化。由于发病年龄较晚且表现异常,诊断常被其他共济失调和单纯神经系统疾病所困扰。到目前为止,已经报道了3-4种类型的GM1神经节病,其中I型是最常见的表型,发病年龄约6个月。多种形式的GM1神经节病是由GLB1基因突变引起的,但疾病的严重程度和发病年龄直接与有害突变的位置和性质有关。但是,由于其独特的遗传原因和重叠的临床特征,一些研究人员认为GM1神经节病代表一种重叠的疾病谱,而不是四种不同的类型。病例介绍在这里,我们报道了伊朗西南部三个家庭的一种不常见的常染色体隐性遗传性GM1神经节病病态,临床情况令人困惑,这些家庭没有亲戚关系,但都来自“卢尔斯”族裔背景。为了鉴定引起疾病的突变,进行了利用下一代测序的全外显子组测序(WES)。对来自三个家庭的四名患者进行了调查,其发病年龄约为3岁。临床表现为共济失调,门障碍和肌张力障碍,导致轮椅依赖性残疾,智力衰退和一般发育衰退。他们全都出生在近亲家庭,父母之间以前没有类似疾病的报道。在所有患者中均发现了GLB1基因的纯合子错义突变(c。601→G→> A,p.R201C)。使用Sanger测序,在先证者,其父母,祖父母和大家庭成员中确认了此鉴定的突变,从而确认了其常染色体隐性遗传方式。结论我们的研究在具有复杂神经发育发现的患者中发现了一种罕见的GLB1基因致病性错义突变,可以扩大对伊朗儿童期共济失调的鉴别诊断范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号